BofA analyst Joanna Gajuk downgraded Option Care Health (OPCH) to Neutral from Buy with a $22 price target The firm, which worries that pressures from payors and increased competition could be structural and will take time to offset, awaits more clarity on Option Care’s ability to manage these challenges.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health price target lowered to $26 from $38 at Deutsche Bank
- Option Care Health: Execution Risks, CID Headwinds Prompt EBITDA Cut and Price Target Reduction to $23, Supporting Hold Rating
- Option Care Health Balances CID Hit With Stable Profits
- Option Care Health price target lowered to $32 from $38 at Citizens
- Option Care Health falls -29.7%